Out-licensing opportunities

pipelineVernalis invites expressions of interest for the following candidates. Please click on the table for detailed information.

Product Indication Late Research Pre-Clinical Phase I Phase II Phase III Marketed Marketing Rights Peak Sales
V85546 Inflammatory Disease late research pre-clinical phase I Worldwide $$

Latest News

Wednesday, 02 May 2012

Successful Outcome for V81444 in Phase I Study

Vernalis today announces the successful outcome of its Phase I trial of V81444